A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Published Date: 15 May 2024

Scientists at Johns Hopkins Medicine have discovered that up to 4.5 percent of papillary nevi may be explained by particular variations in three genes linked to maintaining the length of telomeres, the protective DNA endcaps on chromosomes.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate cancer detection with PET CT and PET MRI is comparable.

2.

Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.

3.

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

4.

Scientists call into question safety of potential new anticancer treatment

5.

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot